Get in touch Subscribe Today

Menu

Issue Preview

BACK TO TOP

2020 Winner

Stempeutics Research Pvt Ltd

Voting for the Best Indian Excellence Awards is now closed.

About

Stempeutics Research Pvt Ltd

Indian Excellence Awards - 2020

Stempeutics Research Bangalore is a late stage life science company focused on developing and commercializing novel therapeutics based on adult stem cells. Company’s flagship product - Stempeucel® is a Phase III ready, allogeneic, cultured, pooled, off-the-shelf, bone marrow derived mesenchymal stromal cell (“MSC”) product. Stempeucel® is being developed for the treatment of Critical Limb Ischemia, Osteoarthritis and non-healing Diabetic Foot Ulcer. Stempeucel® is the FIRST innovative stem cell based biological product to get conditional marketing approval by DCGI (Indian FDA) for the treatment of Critical Limb Ischemia due to Buerger’s disease. Currently Phase 4/PMS study is in progress in India. Stempeutics is seeking partners for further clinical development and commercialization of Stempeucel® in US/Europe/Japan. Contact: BN Manohar MD & CEO Stempeutics Research, Bangalore, India Email: [email protected] Website: www.stempeutics.com Phone: 91-99456-30983